AssureCKD
AssureCKD provides a portable, lab-grade chronic kidney disease (CKD) testing platform that enables clinics to perform uACR and dual-marker eGFR screening in a single appointment. The MATLOC system streamlines sample collection, analysis, and result reporting, integrating with EMRs and billing to maintain workflow efficiency while generating revenue from day one. By delivering fast, affordable results, it helps providers detect early-stage CKD and meet value-based care guidelines.
- Healthcare Technology
- Medical Devices
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Despite guidelines from KDIGO, ADA, and the National Kidney Foundation, fewer than 50% of at-risk patients are screened for CKD. The traditional 4-step testing process loses patients at every step, resulting in a cumulative completion rate of just 52% even when each step has 85% adherence.
Solution
AssureCKD provides a portable, lab-grade chronic kidney disease (CKD) testing platform that enables clinics to perform uACR and dual-marker eGFR screening in a single appointment. The MATLOC system streamlines sample collection, analysis, and result reporting, integrating with EMRs and billing to maintain workflow efficiency while generating revenue from day one. By delivering fast, affordable results, it helps providers detect early-stage CKD and meet value-based care guidelines. The platform is process-mapped to avoid disrupting clinic flow and supports CMS Value-Based Care objectives.
Target Audience
Primary customers are primary care clinics and healthcare providers who need to screen at-risk patients for chronic kidney disease in a single appointment, including those serving populations with diabetes, cardiovascular disease, and other CKD risk factors.
Features
- Lab-grade equivalent results for uACR and dual-marker eGFR testing
- Portable, point-of-care design that is fast and affordable
- Four-step workflow: Sample, Insert, Analyze, Act
- EMR and billing system compatibility
- Revenue-generating from day one (post-reimbursement approval)
- Supports CMS Value-Based Care objectives